Effect of probiotics on the obese patient. A review study
DOI:
https://doi.org/10.56294/sctconf2023549Keywords:
Probiotics, Obesity, Gut Microbiota, DysbiosisAbstract
Introduction: the gut microbiota is a potential determining factor in the development of obesity, resulting in dysbiosis, which is related to a lower number of members of the Bacteroidetes division and an increase in Firmicutes leading to a decrease in energy expenditure, it is also associated with the inflammatory process, insulin resistance and type 2 diabetes mellitus.
Objective: to conduct a literature review related to the effects of probiotics on the improvement of the intestinal microbiota in an obese patient and its associated disorders.
Methods: a search of articles in PubMed, Google Scholar and Elsevier from the last five years was conducted using the terms "obesity and probiotics", "effect of probiotics", "gut microbiota and probiotics". A total of 23 articles were included in the selection criteria.
Results: supplementation with probiotics specifically certain strains such as Lactobacillus plantarum and Bifidobacterium could lead to significant weight reductions, in combination with energy restriction and physical activity. However, it is important to develop clinical trials that are properly designed, including all aspects of lifestyle, gut microbiota, metabolites, and genetic background.
Conclusions: despite the beneficial effects, they are not yet considered an alternative strategy in the treatment of obesity due to the lack of research in this field, since the currently available data come from studies conducted in animals that may not present potential in humans. It is important to conduct more large-scale longitudinal studies with longer follow-up.
References
1. Mayta-Tovalino F, Diaz-Arocutipa C, Piscoya A, Hernandez AV. Effects of Probiotics on Intermediate Cardiovascular Outcomes in Patients with Overweight or Obesity: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12(7):2554. Disponible en: https://www.mdpi.com/2077-0383/12/7/2554
2. La obesidad es un factor de riesgo y un desafío de salud pública. 2024. Disponible en: https://www.paho.org/es/noticias/5-3-2024-obesidad-es-factor-riesgo-desafio-salud-publica
3. Obesidad. 2016. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
4. Encuesta Nacional de Salud y Nutrición. 2018. Disponible en: https://www.ecuadorencifras.gob.ec/documentos/web-inec/Estadisticas_Sociales/ENSANUT/ENSANUT_2018/Principales%20resultados%20ENSANUT_2018.pdf
5. Álvarez-Arraño V, Martín-Peláez S. Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review. Nutrients. 17 de octubre de 2021;13(10):3627. Disponible en: https://www.mdpi.com/2072-6643/13/10/3627
6. Oniszczuk A, Oniszczuk T, Gancarz M, Szymańska J. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases. Molecules. 2021;26(4):1172. Disponible en: https://www.mdpi.com/1420-3049/26/4/1172
7. Mazloom K, Siddiqi I, Covasa M. Probiotics: How Effective Are They in the Fight against Obesity? Nutrients. 2019;11(2):258. Disponible en: http://www.mdpi.com/2072-6643/11/2/258
8. Mitev K, Taleski V. Association between the Gut Microbiota and Obesity. Open Access Maced J Med Sci. 2019;7(12):2050-6. Disponible en: https://spiroski.migration.publicknowledgeproject.org/index.php/mjms/article/view/oamjms.2019.586
9. Soares, Deidiana Kelly Nascimento Souza. Modulação da microbiota intestinal com probióticos e sua relação com a obesidade. Revista de Divulgação Científica Sena Aires. 2019;356-66.
10. Uusitupa HM, Rasinkangas P, Lehtinen MJ, Mäkelä SM, Airaksinen K, Anglenius H, et al. Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research. Nutrients. 2020;12(4):892. Disponible en: https://www.mdpi.com/2072-6643/12/4/892
11. Rahayu ES, Mariyatun M, Putri Manurung NE, Hasan PN, Therdtatha P, Mishima R, et al. Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol. 2021;27(1):107-28. Disponible en: https://www.wjgnet.com/1007-9327/full/v27/i1/107.html
12. Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements. BioMed Res Int. 2019; 2019:1-20. Disponible en: https://www.hindawi.com/journals/bmri/2019/3291367/
13. Lauw S, Kei N, Chan PL, Yau TK, Ma KL, Szeto CYY, et al. Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial. Nutrients. 2023;15(19):4248. Disponible en: https://www.mdpi.com/2072-6643/15/19/4248
14. Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-103. Disponible en: https://www.nature.com/articles/s41591-019-0495-2
15. Quiroz-Eraso S, Rodríguez-Castaño GP, Acosta-González A. Interactions between polyphenols from Theobroma cacao and Lactobacillales to evaluate the potential of a combined strategy for intestinal free-fatty acid removal. Curr Res Food Sci. 2023;7:100594. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S2665927123001624
16. Jacouton E, Mondot S, Langella P, Bermúdez-Humarán LG. Impact of Oral Administration of Lactiplantibacillus plantarum Strain CNCM I−4459 on Obesity Induced by High-Fat Diet in Mice. Bioengineering. 2023;10(10):1151. Disponible en: https://www.mdpi.com/2306-5354/10/10/1151
17. Lee J, Park S, Oh N, Park J, Kwon M, Seo J, et al. Oral intake of Lactobacillus plantarum L‐14 extract alleviates TLR2‐ and AMPK‐mediated obesity‐associated disorders in high‐fat‐diet‐induced obese C57BL/6J mice. Cell Prolif. 2021;54(6):e13039. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/cpr.13039
18. Cai H, Wen Z, Zhao L, Yu D, Meng K, Yang P. Lactobacillus plantarum FRT4 alleviated obesity by modulating gut microbiota and liver metabolome in high-fat diet-induced obese mice. Food Nutr Res. 2022;66. Disponible en: https://foodandnutritionresearch.net/index.php/fnr/article/view/7974
19. Le Barz M, Daniel N, Varin TV, Naimi S, Demers-Mathieu V, Pilon G, et al. Identification de nouvelles bactéries probiotiques contre le développement de désordres métaboliques dans un modèle de souris soumises à une diète obésogène. Nutr Clin Métabolisme. 2019;33(1):22. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0985056219302560
20. Sun NY, Chen S, Li Y. Lactobacillus paracasei L9 ameliorated obesity-associated metabolic parameters and relevant gut microbiota in mice fed a high-fat diet. Nutr Res. 2023; 115:26-37. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0271531723000283
21. Kou R, Wang J, Li A, Wang Y, Zhang B, Liu J, et al. Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. Nutrients. 2023; 15(19):4104. Disponible en: https://www.mdpi.com/2072-6643/15/19/4104
22. Mo SJ, Lee K, Hong HJ, Hong DK, Jung SH, Park SD, et al. Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on Overweight and the Gut Microbiota in Humans: Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Nutrients. 2022; 14(12):2484. Disponible en: https://www.mdpi.com/2072-6643/14/12/2484
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Milena Alexandra Montachana Crespata, Carmen Patricia Viteri Robayo (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
